NO885090L - Polypeptider. - Google Patents

Polypeptider.

Info

Publication number
NO885090L
NO885090L NO88885090A NO885090A NO885090L NO 885090 L NO885090 L NO 885090L NO 88885090 A NO88885090 A NO 88885090A NO 885090 A NO885090 A NO 885090A NO 885090 L NO885090 L NO 885090L
Authority
NO
Norway
Prior art keywords
hiv
polypeptides
env
antigenic
virus
Prior art date
Application number
NO88885090A
Other languages
English (en)
Other versions
NO175153C (no
NO175153B (no
NO885090D0 (no
Inventor
Wilhelm Bannwarth
Patrick Caspers
Stuart Le Grice
Jan Mous
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO885090D0 publication Critical patent/NO885090D0/no
Publication of NO885090L publication Critical patent/NO885090L/no
Publication of NO175153B publication Critical patent/NO175153B/no
Publication of NO175153C publication Critical patent/NO175153C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO885090A 1987-11-16 1988-11-15 Polypeptider NO175153C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH445487 1987-11-16

Publications (4)

Publication Number Publication Date
NO885090D0 NO885090D0 (no) 1988-11-15
NO885090L true NO885090L (no) 1989-05-18
NO175153B NO175153B (no) 1994-05-30
NO175153C NO175153C (no) 1994-09-07

Family

ID=4276428

Family Applications (1)

Application Number Title Priority Date Filing Date
NO885090A NO175153C (no) 1987-11-16 1988-11-15 Polypeptider

Country Status (11)

Country Link
US (1) US5874533A (no)
EP (1) EP0316695B1 (no)
JP (1) JP2887238B2 (no)
AT (1) ATE87487T1 (no)
AU (1) AU630861B2 (no)
DE (1) DE3879881D1 (no)
DK (1) DK637988A (no)
ES (1) ES2054769T3 (no)
FI (1) FI885296A (no)
NO (1) NO175153C (no)
NZ (1) NZ226904A (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976785A (en) * 1986-01-22 1999-11-02 Institut Pasteur Competitive assays for determining the effectiveness of a human immunodeficiency virus type 2 (HIV-2) antiviral agent, employing peptides and proteins of HIV-2
US5830641A (en) * 1986-01-22 1998-11-03 Institut Pasteur In vitro diagnostic assays for the detection of HIV-1 or HIV-2 employing viral-specific antigens and antibodies
US5306614A (en) * 1986-01-22 1994-04-26 Institut Pasteur Methods and kits for diagnosing human immunodeficiency virus type 2(HIV-2)
US6514691B1 (en) 1986-01-22 2003-02-04 Institut Pasteur Peptides of human immunodeficiency virus type 2 (HIV-2), antibodies against peptides of HIV-2, and methods and kits for detecting HIV-2
US5580739A (en) 1986-01-22 1996-12-03 Institut Pasteur Peptides of human immunodeficiency virus type 2 (HIV-2) and in vitro diagnostic methods and kits employing the peptides for the detection of HIV-2
US4839288A (en) * 1986-01-22 1989-06-13 Institut Pasteur Retrovirus capable of causing AIDS, antigens obtained from this retrovirus and corresponding antibodies and their application for diagnostic purposes
US6054565A (en) 1986-03-03 2000-04-25 Institut Pasteur Nucleic Acids of HIV-2, Diagnostic Test Kit and Method using Nucleic Acid Probes of HIV-2
EP0362927A3 (en) * 1988-10-06 1990-11-14 Akzo N.V. Synthetic polypeptides immunochemically reactive with hiv antibodies
GB9005829D0 (en) * 1990-03-15 1990-05-09 Proteus Biotech Ltd Synthetic polypeptides
US5439829A (en) * 1991-01-30 1995-08-08 Eli Lilly And Company Immobilization of biologically active molecules by changing the Oxidation state of a chelated transition metal ion
GB9200117D0 (en) * 1992-01-06 1992-02-26 Connaught Lab Production of recombinant chimeric proteins for vaccine use
US9150605B2 (en) 2002-11-05 2015-10-06 Isis Pharmaceuticals, Inc. Compositions comprising alternating 2′-modified nucleosides for use in gene modulation
US20060160783A1 (en) * 2004-12-30 2006-07-20 Transform Pharmaceuticals, Inc. Novel omeprazole forms and related methods

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4569794A (en) * 1984-12-05 1986-02-11 Eli Lilly And Company Process for purifying proteins and compounds useful in such process
PT84182B (pt) * 1986-01-22 1989-09-14 Pasteur Institut Novo retrovirus susceptivel de provocar o sida, meios e processos para a sua deteccao "in vitro"
US4925784A (en) * 1986-04-04 1990-05-15 Hoffmann-La Roche Inc. Expression and purification of an HTLV-III gag/env gene protein
EP0283327B1 (fr) * 1987-01-16 1997-06-25 Institut Pasteur Peptides ayant des propriétés immunologiques de HIV-2
DE3850593T3 (de) * 1987-03-25 2001-01-04 Genetic Systems Corp., Seattle Synthetische Antigene zur Bestimmung der AIDS-bezogenen, von LAV-2 verursachten Krankheiten.
US4812556A (en) * 1987-05-18 1989-03-14 Virovahl Synthetic peptide antigen for the detection of HIV-2 infection
FR2620030B1 (fr) * 1987-09-07 1990-03-23 Transgene Sa Vecteur d'expression des proteines du virus hiv-2, un agent causal du sida, culture cellulaire infectee ou transformee par ce vecteur, proteines obtenues, vaccin et anticorps obtenus
EP0339389B1 (de) * 1988-04-25 1993-09-22 F. Hoffmann-La Roche Ag Diagnose-Hilfsmittel

Also Published As

Publication number Publication date
AU2507688A (en) 1989-05-18
DK637988A (da) 1989-05-17
NO175153C (no) 1994-09-07
DE3879881D1 (de) 1993-05-06
EP0316695A1 (de) 1989-05-24
AU630861B2 (en) 1992-11-12
ATE87487T1 (de) 1993-04-15
US5874533A (en) 1999-02-23
JP2887238B2 (ja) 1999-04-26
FI885296A (fi) 1989-05-17
DK637988D0 (da) 1988-11-15
NO175153B (no) 1994-05-30
EP0316695B1 (de) 1993-03-31
NZ226904A (en) 1991-08-27
NO885090D0 (no) 1988-11-15
JPH01160998A (ja) 1989-06-23
FI885296A0 (fi) 1988-11-16
ES2054769T3 (es) 1994-08-16

Similar Documents

Publication Publication Date Title
EP0245362A4 (en) SYNTHETIC PEPTIDES AND THEIR USE FOR DIAGNOSIS AND VACCINATION AGAINST AIDS AND ITS ASSOCIATED COMPLEX.
NO863803L (no) Vaksiner og immunoanalyser for ervervet immunsviktsyndrom (aids).
SE8701413D0 (sv) Expression and purification of an htlv-iii gag/env gene protein
DK11789A (da) Rekombinante vaccinia-vira
ES2099066T3 (es) Antigenos a partir de adn sintetico derivado del virus de la inmunodeficiencia humana (hiv-1).
NO885090D0 (no) Polypeptider.
AU571128B2 (en) Expression of immunologically reactive aids viral protein
GR3031817T3 (en) DNA sequences encoding modified retroviral gag polypeptides and vaccines containing them or aggregates thereof.
DE69133599D1 (de) Enterisch übertragendes non-a/non-b-hepatitis-virus agens und charakteristische epitope von selbigem
ATE109512T1 (de) Expression und diagnose mit gag-kodierten peptiden, die mit antikörpern gegen lav immunologisch reaktiv sind.
DE69231705D1 (de) Gag-Env Fusion-Antigen aus HIV
DK498387A (da) Virus-dna-sekvens
DE3853693D1 (de) DNA- und RNA-Moleküle des westlichen Subtyps des FSME-Virus, Polypeptide, die von diesen Molekülen codiert werden, und deren Verwendung.
FR2600079B1 (fr) Vecteur viral et adn recombinant codant pour la proteine f du virus agent causal du s.i.d.a., culture cellulaire infectee par ce vecteur, procede de preparation de la proteine, proteine obtenue, vaccin et anticorps obtenus
AU2190288A (en) Vector for the expression of proteins of the HIV-2 virus, one of the casual agents of AIDS, cell culture infected or transformed by this vector, proteins obtained, vaccine and antibodies obtained
PT90800A (pt) Processo para a preparacao de antigenios precursores das glicoproteinas de involucro de um retrovirus humano hiv-2 e de antigenios que apresentem uma analogia imonulogiga com estes ultimos e sua aplicacao ao diagnostico
KR950000879A (ko) 신규한 인간 면역결핍 바이러스-2(hiv-2)